RDIA
GH icon

RE Dickinson Investment Advisors’s Guardant Health GH Stock Holding History

RE Dickinson Investment Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-45
Closed -$5K – 299
2021
Q4 		$5K Buy
+45
New +$4.65K ﹤0.01% 213

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

RE Dickinson Investment Advisors's GH Position: Q1 2022 in Review

RE Dickinson Investment Advisors sold out of Guardant Health (GH) in Q1 2022, closing a stake of 45 shares — an estimated $5K sold.

RE Dickinson Investment Advisors first reported a position in GH in Q4 2021 and held it in 1 quarter. The position peaked at $5K in Q4 2021. 355 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • RE Dickinson Investment Advisors reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • RE Dickinson Investment Advisors sold 45 Guardant Health shares in Q1 2022, an estimated $5K.
  • RE Dickinson Investment Advisors first reported a position in Guardant Health in Q4 2021 and held it in 1 quarter.
  • RE Dickinson Investment Advisors's Guardant Health position peaked at $5K in Q4 2021.
  • 355 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on RE Dickinson Investment Advisors's 13F filing for Q1 2022, filed 5 May 2022.